Patent: 10,239,937
✉ Email this page to a colleague
Summary for Patent: 10,239,937
Title: | Treatment of paroxysmal nocturnal hemoglobinuria, hemolytic anemias and disease states involving intravascular and extravascular hemolysis |
Abstract: | Methods for treating subjects having complement-mediated hemolytic disorders, such as paroxysmal nocturnal hemoglobinuria (PNH) and other hemolytic anemias, the method comprising administering an effective amount of a composition that inhibits the activity of the complement alternative pathway. |
Inventor(s): | Holers; V. Michael (Denver, CO), Risitano; Antonio M. (Naples, IT) |
Assignee: | Alexion Pharmaceuticals, Inc. (Boston, MA) |
Application Number: | 13/505,150 |
Patent Claims: | see list of patent claims |
Details for Patent 10,239,937
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Alexion Pharmaceuticals, Inc. | SOLIRIS | eculizumab | Injection | 125166 | 03/16/2007 | ⤷ Try a Trial | 2029-11-05 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |